Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Shin Nippon Biomedical Laboratories (SNBL)

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 6
Rounds per year 0.12
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Life Science
Summary

Shin Nippon Biomedical Laboratories (SNBL) is the famous Corporate Investor, which was founded in 1957. The company was established in Asia in Japan. The main office of represented Corporate Investor is situated in the Tokyo.

The top activity for fund was in 2013. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2019. Opposing the other organizations, this Shin Nippon Biomedical Laboratories (SNBL) works on 21 percentage points more the average amount of lead investments.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Shin Nippon Biomedical Laboratories (SNBL), startups are often financed by National Science Foundation, TPG Biotech, RA Capital Management. The meaningful sponsors for the fund in investment in the same round are tella, Nikon, Dainippon Sumitomo Pharma. In the next rounds fund is usually obtained by Mitsubishi UFJ Capital, incTANK Ventures, Tohoku University Venture Partners.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Therapeutics, Medical. Among the various public portfolio startups of the fund, we may underline Agrivida, TMS Co., Ltd., Healios K.K The fund has specific favorite in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Shin Nippon Biomedical Laboratories (SNBL):
Typical Co-investors
Shin Nippon Biomedical Laboratories (SNBL) is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Shin Nippon Biomedical Laboratories (SNBL):
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arancia International Guadalajara, Jalisco, Mexico
Ascenion GmbH -
Aviva Investors England, London, United Kingdom
Climate Pledge Fund -
D-Prize California, San Francisco, United States
DCP Capital Beijing, Beijing, China
Diaspora Ventures -
East of England Co-operative Society Limited -
Enable Capital Management California, San Francisco, United States
Fayez Sarofim & Co. Houston, Texas, United States
GPS Ventures GmbH Berlin, Berlin, Germany
Marin Investments British Columbia, Canada, Vancouver
Matsui Securities Chiyoda, Japan
NGP Energy Technology Partners District of Columbia, United States, Washington
Nouville Holdings Canada, Ontario, Ottawa
Rothesay Pensions Management England, London, United Kingdom
Transformation Partner Copenhagen, Denmark, Hovedstaden

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Satsuma Pharmaceuticals

Biotechnology
Pharmaceutical
Therapeutics
$62M24 Apr 2019 South San Francisco, California, United States

TMS

Biotechnology
Life Science
Pharmaceutical
$330K01 Nov 2011 Fuchu

Agrivida

Biofuel
Biomass Energy
Biotechnology
$600K22 Nov 2006 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Shin Nippon Biomedical Laboratories (SNBL)?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 23M
Rounds per year 0.12
Peak activity year 2019
Lead investments 0
Follow on index 0.25
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Satsuma Pharmaceuticals

Biotechnology
Pharmaceutical
Therapeutics
$62M24 Apr 2019 South San Francisco, California, United States

TMS

Biotechnology
Life Science
Pharmaceutical
$330K01 Nov 2011 Fuchu

Agrivida

Biofuel
Biomass Energy
Biotechnology
$600K22 Nov 2006 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: